Medtronic (MDT) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Medtronic · Health Care · ref. ETF XLV · 51 calls · price $93.01
What the company does: Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
📈 Medtronic (MDT) stock price
$93.01-3.7% over range
Oct 14, 25low $73.75 · high $105.35Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
69% recommend buying · 16 analysts
📊 JPI status : Medtronic is no longer in our current JPI rankings, but appeared in the past (2017) — its upside may be behind it. See the stocks picked in 2017 →
🎯 MDT price target & analyst consensus — price $93.01
The price target · all analysts combined (16 targets)
Highest target · 1 firm of 16$118+26.9%
Median target · of 16 targets$102+9.7%
Lowest target · 1 firm of 16$83-10.8%
Current price$93.01
Where these 16 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1594%
$95 ↔ $118
Below
16%
$83
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Stifel — 68% of its targets hit on this sector (304 calls tested). It aims for $95 (+2.1 %), call made on September 3, 2026, maturing on September 3, 2027 (41 d ago).
The 10 reliable analysts
$102+9.7 %
The 6 other firms
$102+9.7 %
How to read it: the 10 reliable firms are not filtered by optimism — 10 aim above the price, 0 below, hence their $102 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 16 ratings (last 6 months)
Strong Buy00%
Buy1169%
Hold531%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 MDT price target all
All 16 calls, one by one, with our verdict on each firm.
→ See all 16 targets, analyst by analyst💡 The best analysts on MDT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in MDT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Medtronic? The JPI assistant answers using our backtest data.
💰 Medtronic dividend: yield, history & growth › open the full page
3.60%annual yield
📈 Steady dividend — 22 yrs of consecutive dividend increases
That's ~$2.85 per share per year.
📈 Medtronic fundamentals: valuation, margins & growth › open the full page
P/E 22.9Net margin 13.9 %Revenue growth +13.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 12 %
2024
Rev +4%Profit −2%
2025
Rev +4%Profit +27%
2026
Rev +8%Profit +3%
🔎 Detailed analyses
🏛️ Which US Congress members hold Medtronic (MDT)?
1 Congress member has disclosed MDT buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Daniel Goldman 1× · 25%
✅ Historical analyst reliability on MDT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| CFRA | 100% | +18.3% | 2 |
| B of A Securities ↗ | 100% | +17.3% | 6 |
| JP Morgan ↗ | 100% | +16.0% | 7 |
| SunTrust Robinson Humphrey | 100% | +2.5% | 3 |
| BTIG ↗ | 86% | +15.7% | 7 |
| Evercore ISI Group ↗ | 80% | +4.3% | 5 |
| Barclays ↗ | 78% | +12.6% | 9 |
| Piper Sandler ↗ | 75% | +20.6% | 4 |
| Jefferies ↗ | 75% | +12.3% | 8 |
| BMO Capital ↗ | 71% | +14.9% | 7 |
See the other 17 firms
| RBC Capital ↗ | 25% | -5.3% | 8 |
| Truist Securities ↗ | 33% | -10.7% | 3 |
| Oppenheimer ↗ | 33% | -5.5% | 6 |
| Cowen & Co. | 33% | -4.4% | 3 |
| Goldman Sachs ↗ | 33% | +7.7% | 3 |
| Raymond James ↗ | 38% | -1.3% | 13 |
| Morgan Stanley ↗ | 43% | -5.7% | 7 |
| UBS ↗ | 45% | +5.7% | 11 |
| Wells Fargo ↗ | 50% | -6.0% | 12 |
| Stifel ↗ | 50% | -4.1% | 6 |
| Argus Research ↗ | 50% | -3.2% | 6 |
| Needham ↗ | 50% | -2.5% | 8 |
| Credit Suisse | 50% | +5.2% | 12 |
| Deutsche Bank ↗ | 55% | +8.2% | 11 |
| Mizuho ↗ | 57% | +4.3% | 7 |
| Citigroup ↗ | 65% | +8.3% | 26 |
| Bernstein ↗ | 67% | +6.4% | 3 |
📊 What $1,000 invested in Medtronic would be worth › open the full page
In short — $1,000 invested in Medtronic 10 years ago would be worth $1,030 today, i.e. +0%/yr on average. Best year: 2019 (+31%), worst: 2022 (-19%). Price performance, excluding dividends.
If I'd invested $1,000 in Medtronic
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $861 | -14% |
| 3 years ago | $935 | -7% |
| 5 years ago | $703 | -30% |
Return by year (Medtronic)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -24% | $760 (-24%) |
| 2025 | +13% | $861 (-14%) |
| 2024 | +4% | $894 (-11%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Medtronic
Loading news…
📋 All analyst calls on MDT
Filtered on — · ✕ show all
▲ Buy · 🎯$99
Price at call : $91.93 — upside +8%
Today : $93.01 — upside +6%
🎯 on MDT : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
■ Equal-Weight neutral · not a buy · 🎯$95
Price at call : $85.51 — gap to target +11%
Today : $93.01 — gap to target +2%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
▲ Buy · 🎯$110
Price at call : $86.29 — upside +27%
Today : $93.01 — upside +18%
🎯 on MDT : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Sep 30, 27
matures : Sep 30, 27
▲ Buy · 🎯$110
Price at call : $94.17 — upside +17%
Today : $93.01 — upside +18%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Sep 3, 27
matures : Sep 3, 27
Truist Securities ↗
Sep 2, 26
■ Hold neutral · not a buy · 🎯$99
Price at call : $93.1 — gap to target +6%
Today : $93.01 — gap to target +6%
🎯 on MDT : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
Wells Fargo ↗
Sep 2, 26
▲ Overweight · 🎯$104
Price at call : $93.1 — upside +12%
Today : $93.01 — upside +12%
🎯 on MDT : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
RBC Capital ↗
Sep 2, 26
▲ Outperform · 🎯$118
Price at call : $92.18 — upside +28%
Today : $93.01 — upside +27%
🎯 on MDT : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
B of A Securities ↗
Sep 2, 26
▲ Buy · 🎯$110
Price at call : $92.18 — upside +19%
Today : $93.01 — upside +18%
🎯 on MDT : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
See the other 43 calls, newest to oldest
■ Hold neutral · not a buy · 🎯$95
Price at call : $92.18 — gap to target +3%
Today : $93.01 — gap to target +2%
🎯 on MDT : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
■ Neutral neutral · not a buy · 🎯$100
Price at call : $92.18 — gap to target +8%
Today : $93.01 — gap to target +8%
🎯 on MDT : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
▲ Buy · 🎯$100
Price at call : $92.18 — upside +8%
Today : $93.01 — upside +8%
🎯 on MDT : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Sep 1, 27
matures : Sep 1, 27
▲ Buy · 🎯$114
Price at call : $92.04 — upside +24%
Today : $93.01 — upside +23%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Sep 1, 27
matures : Sep 1, 27
▲ Buy · 🎯$110
Price at call : $90.65 — upside +21%
Today : $93.01 — upside +18%
🎯 on MDT : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 28, 27
matures : Aug 28, 27
▲ Buy · 🎯$114
Price at call : $89.97 — upside +27%
Today : $93.01 — upside +23%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Buy · 🎯$91
Price at call : $94.13 — upside -3%
Today : $93.01 — upside -2%
🎯 on MDT : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
▲ Buy · 🎯$100
Price at call : $87.54 — upside +14%
Today : $93.01 — upside +8%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
▲ Buy · 🎯$100
Price at call : $83.57 — upside +20%
Today : $93.01 — upside +8%
🎯 on MDT : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 10, 27
matures : Jul 10, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$105
Price at call : $83.83 — upside +25%
Today : $93.01 — upside +13%
🎯 on MDT : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Buy · 🎯$101
Price at call : $78.14 — upside +29%
Today : $93.01 — upside +9%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Jun 17, 27
matures : Jun 17, 27
Goldman Sachs ↗
Jun 5, 26
■ Neutral neutral · not a buy · 🎯$83
Price at call : $80.69 — gap to target +3%
Today : $93.01 — gap to target -11%
🎯 on MDT : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
▲ Outperform · 🎯$97
Price at call : $80.69 — upside +20%
Today : $93.01 — upside +4%
🎯 on MDT : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $81.67 — gap to target +4%
Today : $93.01 — gap to target -9%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$119
Price at call : $81.67 — upside +46%
Today : $93.01 — upside +28%
🎯 on MDT : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
RBC Capital ↗
Jun 4, 26
▲ Outperform · 🎯$118
Price at call : $81.93 — upside +44%
Today : $93.01 — upside +27%
🎯 on MDT : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Wells Fargo ↗
Jun 4, 26
▲ Overweight · 🎯$102
Price at call : $81.93 — upside +24%
Today : $93.01 — upside +10%
🎯 on MDT : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Leerink Partners ↗
Jun 4, 26
▲ Outperform · 🎯$104
Price at call : $81.93 — upside +27%
Today : $93.01 — upside +12%
🎯 on MDT : 0% (1 call matured) · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $81.93 — gap to target +4%
Today : $93.01 — gap to target -9%
🎯 on MDT : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$90
Price at call : $81.93 — upside +10%
Today : $93.01 — upside -3%
🎯 on MDT : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Outperform · 🎯$100
Price at call : $81.93 — upside +22%
Today : $93.01 — upside +8%
🎯 on MDT : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
▲ Buy · 🎯$101
Price at call : $81.93 — upside +23%
Today : $93.01 — upside +9%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
■ Neutral neutral · not a buy · 🎯$90
Price at call : $83.79 — gap to target +7%
Today : $93.01 — gap to target -3%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Truist Securities ↗
Apr 15, 26
■ Hold neutral · not a buy · 🎯$95
Price at call : $85.65 — gap to target +11%
Today : $93.01 — gap to target +2%
🎯 on MDT : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Outperform · 🎯$120
Price at call : $88.12 — upside +36%
Today : $93.01 — upside +29%
🎯 on MDT : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 9, 26
▲ Outperform · 🎯$106
Price at call : $87.21 — upside +22%
Today : $93.01 — upside +14%
🎯 on MDT : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
▲ Buy · 🎯$110
Price at call : $88.65 — upside +24%
Today : $93.01 — upside +18%
🎯 on MDT : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$108
Price at call : $86.42 — upside +25%
Today : $93.01 — upside +16%
🎯 on MDT : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
Argus Research ↗
Apr 6, 26
▲ Buy · 🎯$115
Price at call : $86.42 — upside +33%
Today : $93.01 — upside +24%
🎯 on MDT : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Overweight · 🎯$120
Price at call : $86.63 — upside +39%
Today : $93.01 — upside +29%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 1, 27
matures : Apr 1, 27
Piper Sandler ↗
Apr 1, 26
■ Neutral neutral · not a buy · 🎯$91
Price at call : $86.63 — gap to target +5%
Today : $93.01 — gap to target -2%
🎯 on MDT : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Apr 1, 27
matures : Apr 1, 27
▲ Buy · 🎯$120
Price at call : $87.67 — upside +37%
Today : $93.01 — upside +29%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Mar 26, 27
matures : Mar 26, 27
▲ Buy · 🎯$120
Price at call : $88.97 — upside +35%
Today : $93.01 — upside +29%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Mar 10, 27
matures : Mar 10, 27
■ Neutral neutral · not a buy · 🎯$100
Price at call : $97.58 — gap to target +2%
Today : $93.01 — gap to target +8%
🎯 on MDT : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Overweight · 🎯$118
Price at call : $97.58 — upside +21%
Today : $93.01 — upside +27%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
■ Neutral neutral · not a buy · 🎯$100
Price at call : $98.49 — gap to target +2%
Today : $93.01 — gap to target +8%
🎯 on MDT : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Buy · 🎯$120
Price at call : $96.41 — upside +24%
Today : $93.01 — upside +29%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
▲ Buy · 🎯$121
Price at call : $101.65 — upside +19%
Today : $93.01 — upside +30%
🎯 on MDT : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
■ Neutral neutral · not a buy · 🎯$104
Price at call : $102.95 — gap to target +1%
Today : $93.01 — gap to target +12%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
▲ Outperform · 🎯$112
Price at call : $96.95 — upside +16%
Today : $93.01 — upside +20%
🎯 on MDT : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Overweight · 🎯$116
Price at call : $97.53 — upside +19%
Today : $93.01 — upside +25%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
William Blair ↗
Jan 6, 26
▲ Outperform
🎯 on MDT : no call matured yet · 📊 on Health : 64.3% · +7.1% (28 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
Leerink Partners ↗
Jun 16, 25
▲ Outperform · 🎯$110
Price at call : $87.92 — upside +25%
Today : $93.01 — upside +18%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on MDT : 0% (1 call matured) · 📊 on Health : 53.7% · -6.2% (41 calls)
-7.5%
stock -8% · XLV +13%
matured Jun 16, 26
Frequently asked questions
Should I buy Medtronic stock?
This isn't buy advice. For Medtronic, the analyst consensus is "Buy", with an average price target of $102 (+10% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Medtronic). We show the numbers — you decide.
Is it too late to buy Medtronic? How high can it go?
The most bullish analyst target on Medtronic is $118 (+27% above today's price); the average is $102. That's the upside they see. Check how reliable those analysts have actually been on Medtronic on our site before trusting it.
Is Medtronic still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 27 analysts have a real record on Medtronic, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Medtronic? The case for and against
The arguments for and against, one by one, from the numbers: why invest in MDT (and why hesitate).
What has Medtronic's past performance been?
Historical returns and a "how much if I had invested" calculator: MDT performance & returns.
Does Medtronic pay a dividend?
Yield, consistency and growth history of the dividend: MDT's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX